Lisondra, Jhon Kyle .

HRN: 23-62-73  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2023
CEFUROXIME 750MG (VIAL)
09/01/2023
09/08/2023
IV
276mg
Q8
PCAP C
Waiting Final Action 
09/02/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
09/02/2023
09/09/2023
IV
42mg
OD
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: